Asthma Management in CHildren Based on Exhaled Nitric Oxide - Randomised Controlled Trial

Asthma Management in Children Based on Exhaled Nitric Oxide - Randomised Controlled Trial

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000321640

Enrollment

110

Registered

2005-09-06

Start date

2006-01-31

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Adjust treatment according to exhaled nitric oxide result, monthly for 4 months, then second monthly for 8 months. Duration of study is 12 months.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

4 Years to No maximum

Healthy volunteers

Inclusion criteria

Children with asthma attending a paediatric specialist clinic.

Exclusion criteria

Presence of other cardiorespiratory illness such as CF, trachemalacia, etc.Poorly compliant to treatment.Inability to take ICS or long acting beta-2-antagonists (LABA).

Outcome results